Bridging the Gap: Key Considerations for Physicians Interpreting Gallium-Based PET Imaging
Key opinion leaders offer insights on closing knowledge gaps and highlight crucial factors for physicians to consider when interpreting gallium-based PET imaging results in clinical practice.
Video Player is loading.
Video content above is prompted by the following:
- What key aspects of gallium-based PET imaging should physicians interpreting other modalities understand, and what advice do you have to address any unfamiliar nuances or challenges they may encounter?
Recent Videos
Cancer Imaging and the Future of Prostate Cancer Care
Understanding and Managing Intermediate-Risk Prostate Cancer
Navigating Inter-readability Issues in Nuclear Medicine: Solutions for Limited Specialist Availability
Collaboration in Prostate Cancer Care: The Role of PSMA PET Imaging in Multidisciplinary Teams
Optimal Timing and Frequency of Imagining Agents Used in the Detection and Characterization of Oligometastatic Prostate Cancer
Evaluating Imaging Agents in Oligometastatic Prostate Cancer: A Comparative Analysis of Gallium-Based and Non-Gallium-Based Options
Navigating Oligometastatic Disease: Understanding Lesion Numbers, Metastasis, and Disease Cutoffs in Clinical Practice
Understanding Oligometastatic Disease in Prostate Cancer: Insights from PSMA PET Imaging
The Role of PSMA PET in Early Detection and Prostate Cancer Staging
Insights into the Benefit of PSMA PET Imaging Alongside Other Conventional Imaging Modalities in Prostate Cancer Care
Related Content
